Why can't a single type of cell do everything? In a complex organism, different functions — support, transport, sensation, contraction — require specialisation. Groups of similar cells performing a common function form tissues, and tissues organised together form organs. This chapter is directly relevant to UPSC questions on organ donation policy, blood as a connective tissue (blood transfusion, bone marrow donation), stem cell therapy, and tissue banking — all of which have appeared in GS2 and GS3 papers.
PART 1 — Quick Reference Tables
Overview: Types of Tissues
| Kingdom | Tissue Category | Main Types |
|---|---|---|
| Plants | Meristematic | Apical, Lateral, Intercalary |
| Plants | Permanent — Simple | Parenchyma, Collenchyma, Sclerenchyma |
| Plants | Permanent — Complex | Xylem, Phloem |
| Animals | Epithelial | Squamous, Cuboidal, Columnar, Ciliated, Glandular |
| Animals | Connective | Blood, Bone, Cartilage, Areolar, Adipose |
| Animals | Muscular | Striated (skeletal), Unstriated (smooth), Cardiac |
| Animals | Nervous | Neurons, Glial cells |
Plant Simple Tissues — Comparison
| Tissue | Cell Type | Cell Wall | Function | Location |
|---|---|---|---|---|
| Parenchyma | Living, thin-walled | Thin, cellulose | Storage, photosynthesis, healing | Cortex, pith, mesophyll |
| Collenchyma | Living, elongated | Unevenly thickened at corners | Mechanical support with flexibility | Leaf stalks, young stems |
| Sclerenchyma | Dead at maturity | Very thick, lignified | Rigid support and protection | Seed coats, nut shells, mature stems |
Xylem vs Phloem — Complex Tissues
| Feature | Xylem | Phloem |
|---|---|---|
| Direction of transport | Upward only (unidirectional) | Both directions (bidirectional) |
| What is transported | Water and minerals | Food (sugars, amino acids) |
| Living components | Xylem parenchyma, xylem fibres | Sieve tubes, companion cells, phloem parenchyma |
| Dead components | Tracheids, vessel elements | Phloem fibres |
| Energy requirement | No (transpiration pull) | Yes (active loading) |
Animal Tissues — Connective Tissue Types
| Type | Matrix | Special Features | Function |
|---|---|---|---|
| Blood | Plasma (liquid) | RBC, WBC, Platelets | Transport of O2, CO2, hormones; immunity |
| Bone | Hard, calcified (calcium phosphate) | Osteocytes in lacunae | Structural support, mineral storage |
| Cartilage | Flexible (chondroitin) | Chondrocytes in lacunae | Cushioning joints, ear, nose, trachea rings |
| Areolar | Loose fibres (collagen, elastin) | Fibroblasts, mast cells | Fills spaces; connects organs |
| Adipose | Fat droplets | Adipocytes | Fat storage; insulation; cushioning |
Muscle Tissue — Three Types
| Feature | Striated (Skeletal) | Unstriated (Smooth) | Cardiac |
|---|---|---|---|
| Location | Attached to bones | Walls of viscera, blood vessels | Heart wall |
| Control | Voluntary | Involuntary | Involuntary |
| Striations | Yes | No | Yes (faint) |
| Nuclei | Many, peripheral | Single, central | Single/double, central |
| Fatigue | Fatigues quickly | Slow, sustained | Never fatigues |
| Cell shape | Long, cylindrical, fibrous | Spindle-shaped | Branched, intercalated discs |
PART 2 — Detailed Notes
1. Why Do Multicellular Organisms Need Tissues?
Division of labour — just as a society functions better when people specialise in different trades, a multicellular organism functions more efficiently when cells specialise. Specialised cells group together into tissues. The degree of specialisation increases from simpler to more complex organisms.
2. Plant Tissues
Meristematic Tissues (meristos = divisible) contain actively dividing cells. They are responsible for growth.
- Apical meristem: Located at root and shoot tips. Responsible for primary growth (increase in length).
- Lateral meristem (cambium): Located on the sides of stems and roots. Responsible for secondary growth (increase in girth). The cork cambium produces bark; vascular cambium produces wood (secondary xylem).
- Intercalary meristem: Located at the base of leaves or internodes. Allows regrowth after grazing (important in grasses).
Permanent Tissues are formed when meristematic cells differentiate and lose the ability to divide. They may be living or dead.
Simple permanent tissues are made of a single cell type:
Parenchyma — the most common plant tissue. Thin-walled, living cells with large vacuoles. Functions include: photosynthesis (chlorenchyma — parenchyma with chloroplasts), storage of starch, water, oils and other substances, and wound healing through dedifferentiation. Aerenchyma (parenchyma with large air spaces) is found in aquatic plants for buoyancy.
Collenchyma — living cells with unevenly thickened cell walls (thickening at corners). Provides mechanical support while allowing flexibility — hence found in young growing stems, leaf stalks (petioles), and leaf ribs. Unlike sclerenchyma, collenchyma can grow with the plant.
Sclerenchyma — cells dead at maturity with heavily lignified (lignin — a complex polymer) cell walls. Two forms: fibres (long, narrow cells for support — linen from flax, jute fibres) and sclereids/stone cells (irregularly shaped, found in hard seed coats and nut shells). Provides rigidity.
Complex permanent tissues are made of more than one cell type:
Xylem components:
- Tracheids — elongated, dead cells with pits in walls. Water moves from tracheid to tracheid through pits. Found in gymnosperms and primitive angiosperms.
- Vessel elements — larger, dead cells that join end-to-end to form continuous vessel tubes (the dominant water-conducting tissue in flowering plants).
- Xylem parenchyma — living, stores food and water.
- Xylem fibres — dead, provide support.
Phloem components:
- Sieve tube elements — living cells (lose nucleus at maturity) stacked to form sieve tubes; perforated sieve plates at ends allow phloem sap to move.
- Companion cells — living cells with nucleus that support sieve tubes metabolically (since sieve tubes lose their nucleus).
- Phloem parenchyma — living, stores food.
- Phloem fibres (bast fibres) — dead, provide support. Commercial fibres like jute come from phloem fibres.
🎯 UPSC Connect: Plant Tissues and Agriculture
Xylem and phloem explain how water, minerals and food move through plants. This directly connects to:
- Drip irrigation efficiency — delivers water directly to root zone where xylem uptake occurs
- Plant grafting — scion and rootstock must have compatible vascular (xylem+phloem) alignment
- Fibre crops — jute fibres are phloem fibres; cotton fibres are seed trichomes; both are GI-tagged products important for agricultural trade
3. Animal Tissues
Epithelial Tissues cover body surfaces, line organs, and form glands. Key types:
- Squamous epithelium — flat cells, forms skin surface, lining of blood vessels and alveoli (enables diffusion)
- Cuboidal epithelium — cube-shaped, kidney tubules and salivary glands
- Columnar epithelium — tall cells, lining of the intestine with microvilli for absorption
- Ciliated epithelium — columnar cells with cilia; lines respiratory tract to sweep mucus and dust upward (mucociliary clearance — impaired in smokers and COVID-19 patients)
- Glandular epithelium — secretes hormones and enzymes
Connective Tissues — scattered cells in an extracellular matrix (ECM). The matrix may be solid (bone), semi-solid (cartilage), or liquid (blood).
Blood — the only liquid connective tissue. Plasma (55%) is the liquid matrix; formed elements (45%) are RBCs (erythrocytes), WBCs (leukocytes), and platelets (thrombocytes). RBCs carry O2 via haemoglobin; WBCs are immune cells; platelets are involved in clotting.
🎯 UPSC Connect: Blood and Policy
- Blood transfusion: ABO and Rh blood group compatibility — basis of India's National Blood Policy
- Anaemia: Low RBC/haemoglobin — India has among the highest anaemia prevalence rates globally; addressed by POSHAN Abhiyaan
- Bone marrow donation: Bone marrow contains haematopoietic stem cells that produce all blood cells — transplants used for leukaemia treatment; DKMS-BMST India is the national registry
- Blood as connective tissue — a frequent MCQ trap (students expect blood to be a fluid, not a tissue)
Bone — calcified connective tissue. Osteocytes (bone cells) sit in lacunae within a hard matrix of collagen fibres and calcium phosphate (hydroxyapatite). Bone is not inert — it is remodelled constantly by osteoblasts (build bone) and osteoclasts (break down bone). Bone marrow inside long bones produces blood cells.
Cartilage — flexible connective tissue. Matrix is chondroitin sulphate. Found in: ear pinna, tip of nose, intervertebral discs, tracheal rings (C-shaped, allow oesophagus to expand during swallowing), and covering the ends of bones at joints (articular cartilage). Unlike bone, cartilage has no blood vessels — this is why cartilage heals slowly after injury.
Muscular Tissue:
- Striated muscle fibres are multi-nucleated (formed by fusion of many cells) — a syncytium.
- Cardiac muscle is unique: it is involuntary like smooth muscle but striated like skeletal muscle. Cardiac cells are connected by intercalated discs (gap junctions) that allow electrical signals to spread rapidly, ensuring the heart contracts as one unit.
Nervous Tissue: Composed of neurons (nerve cells) and glial cells (support cells). A neuron has a cell body (soma), dendrites (receive signals), and an axon (transmits signals to next neuron or muscle). Myelin sheath (from Schwann cells) insulates the axon and speeds up conduction (saltatory conduction). Loss of myelin occurs in multiple sclerosis — an autoimmune disease.
🎯 UPSC Connect: Organ Donation and Tissue Banking
The Transplantation of Human Organs and Tissues Act (THOTA) 1994, amended in 2011, governs organ and tissue donation in India. Key tissues that can be donated include:
- Cornea (epithelial tissue derived) — most donated tissue in India; eye banks operated by NOTTO
- Bone and cartilage — orthopaedic reconstruction
- Skin (epithelial) — burn treatment
- Heart valves (cardiac muscle tissue)
- Blood vessels (smooth muscle + connective tissue)
India's organ donation rate remains among the lowest globally — 0.81 per million population (2024, NOTTO), vs Spain at ~48 per million. India recorded a record 18,911 organ transplants in 2024 (up from ~5,000 in 2013 — nearly 4x rise), yet demand vastly outstrips supply: 2.5 lakh need kidneys annually, 1 lakh need corneas, 80,000 need livers, 50,000 need hearts — while only ~1,000–1,200 deceased donations occur per year. [Additional] THOA Amendment 2023 introduced provisions for swapping/pooling of organs between transplant centers and strengthened penalties for organ trafficking.
PART 3 — Frameworks & Analysis
Framework: Tissue → Organ → Organ System
Tissues do not function in isolation:
- Epithelial + connective + muscular + nervous tissues combine to form the stomach (an organ)
- Multiple organs working together form organ systems (digestive system)
- This hierarchy — cell → tissue → organ → organ system → organism — is foundational for all biology-related GS questions
Framework: UPSC-Relevant Tissue Connections
| Tissue | UPSC Issue | Policy Link |
|---|---|---|
| Blood (connective) | Anaemia, blood banks, transfusion safety | National Blood Policy, Janani Suraksha Yojana |
| Bone marrow | Leukaemia treatment; stem cell therapy | DKMS-BMST donor registry |
| Epithelial (cornea) | Blindness prevention; corneal donation | NOTTO, National Eye Donation Fortnight |
| Cardiac muscle | Heart failure; cardiac arrest | PMJAY cardiology coverage |
| Ciliated epithelium | Respiratory health; impact of air pollution | NCAP (National Clean Air Programme) |
[Additional] 6a. Sickle Cell Disease — A Genetic RBC Disorder and India's Elimination Mission
The chapter covers anaemia under POSHAN Abhiyaan (iron/nutrition deficiency) but misses sickle cell disease — a genetic disease where a point mutation alters haemoglobin structure, deforming red blood cells. This is a direct cellular application of the blood tissue content, and a dedicated national mission makes it a high-value UPSC 2026 topic.
Sickle Cell Disease — How a DNA Mutation Changes RBC Shape: Normal haemoglobin (HbA) has a specific amino acid sequence. In sickle cell disease (SCD), a single point mutation in the beta-globin gene substitutes glutamic acid (hydrophilic) with valine (hydrophobic) — producing haemoglobin S (HbS). When oxygen levels drop, HbS molecules polymerise (stack together), distorting the normally biconcave disc-shaped RBC into a rigid, crescent (sickle) shape.
Consequences at the cellular level:
- Sickle-shaped RBCs cannot pass through narrow capillaries — they block blood flow, causing vaso-occlusive crises (severe pain episodes)
- Sickle cells are fragile and break down faster (lifespan ~10-20 days vs ~120 days for normal RBC) — causing haemolytic anaemia
- Repeated sickling damages organs: spleen, kidneys, lungs, brain
Inheritance: Autosomal recessive. Two sickle cell genes (HbSS) → full disease. One normal + one sickle gene (HbSA or carrier) → sickle cell trait — largely asymptomatic but can pass the gene to children. Carrier × carrier → 25% chance of each child having SCD.
[Additional] National Sickle Cell Anaemia Elimination Mission (NSCAEM) — GS2 (Tribal Health / Genetic Disease Policy):
Launch and mandate:
- Launched by PM Narendra Modi on July 1, 2023 from Shahdol, Madhya Pradesh (a high-burden tribal district)
- Announced in Union Budget 2023-24 under Mission Mode tribal health initiative
- Governed by Ministry of Health and Family Welfare (MoHFW) under the National Health Mission (NHM)
Objectives:
- Screening: Universal screening of 7 crore (70 million) individuals aged 0-40 years in tribal and high-prevalence districts across 17 states by end of FY 2025-26
- Identification: By February 2026 (6.83 crore screened), 21.7 lakh individuals identified: 2.37 lakh with sickle cell disease + 19.32 lakh carriers
- Long-term goal: Eliminate sickle cell disease as a public health problem by 2047 (India's centenary of independence)
Why tribal communities?
- India has an estimated 50+ lakh SCD patients and ~2.5 crore carriers
- The disease is disproportionately concentrated in Scheduled Tribe populations (Adivasi) in Chhattisgarh, Odisha, Gujarat, Maharashtra, Jharkhand, and Madhya Pradesh — where the sickle cell variant historically provided a survival advantage against malaria (carriers are more resistant to falciparum malaria)
- Tribal communities have had very low access to genetic counselling, prenatal diagnosis, and treatment (hydroxyurea — reduces sickling episodes)
Policy tools:
- Mandatory pre-marital genetic counselling for carriers in high-prevalence districts
- Antenatal screening and counselling for carrier couples (25% child risk)
- Hydroxyurea therapy for moderate-to-severe cases (subsidised under NHM)
- Haematopoietic stem cell transplant (bone marrow transplant) — curative but costly; available at select public hospitals
UPSC synthesis: SCD connects three areas: (1) GS3 science — cellular biology of haemoglobin and RBCs; (2) GS2 health policy — mission-mode elimination, tribal health equity; (3) GS1 society — genetic disease burden in marginalised communities, health disparities. The malaria-SCD relationship also links to GS3 infectious disease ecology.
[Additional] 6b. National Blood Transfusion Bill 2025 — Statutory Regulation of Blood Banks
The chapter discusses blood as a connective tissue and organ donation policy, but there is no content on the regulatory framework for blood banks and transfusion safety — a significant governance gap that the National Blood Transfusion Bill 2025 is now addressing.
[Additional] National Blood Transfusion Bill 2025 — GS2 (Health Governance / Regulatory Bodies):
Current gap: India's blood banks operate under the Drugs and Cosmetics Act, 1940 — a law written when blood was not the highly processed multi-component product it is today. There is no dedicated statutory authority for blood; regulatory gaps have allowed uneven quality standards, cold-chain failures, and inadequate voluntary donation incentives.
National Blood Transfusion Bill 2025:
- Proposes establishment of a National Blood Transfusion Authority (NBTA) — a statutory body with powers to set uniform national standards for blood collection, processing, testing, storage, and transfusion
- Penalty: operating without NBTA registration → up to 3 years imprisonment
- Governs the shift from whole blood transfusion to component therapy (separating blood into RBCs, platelets, fresh frozen plasma, cryoprecipitate for targeted treatment — reducing waste and improving outcomes)
India's blood supply data (2024):
- Blood units collected: 14.6 million units (FY 2024-25) — up from 12.6 million (FY 2023-24)
- Voluntary donation: 74.55% of all donations (WHO target: 100% voluntary)
- Infrastructure gap: A 2024 geospatial analysis of 8 northern states found ~60 districts had no licensed blood bank; 80% of primary health centres lacked blood storage/cold-chain infrastructure
UPSC angle: GS2 question template — "inadequate infrastructure and regulatory gaps in India's blood bank system." NBTA joins the list of new regulatory bodies (AERB under SHANTI Act 2025, etc.) — a recurring institutional reform question. Also connects to maternal mortality (post-partum haemorrhage needs immediate blood access in rural areas) and anaemia management.
[Additional] 6b. Stem Cell Research — India's ICMR Guidelines 2025 and Therapeutic Potential
The chapter covers tissues including the concept of meristematic (undifferentiated) cells in plants that can develop into any plant tissue. Stem cells are the animal equivalent — undifferentiated cells capable of self-renewal and differentiation into specialised tissues — with enormous therapeutic potential and a complex ethical and regulatory landscape in India.
Key Terms — Stem Cells:
| Term | Meaning |
|---|---|
| Stem cell | An undifferentiated cell capable of (1) self-renewal (dividing indefinitely to produce more stem cells) and (2) differentiation (developing into specialised cell types — muscle, neuron, blood cell, liver cell, etc.) |
| Embryonic Stem Cells (ESCs) | Derived from the inner cell mass of a blastocyst (early embryo, 4-5 days old); pluripotent — can differentiate into any cell type; highly controversial (requires destruction of human embryo) |
| Adult Stem Cells (ASCs) | Found in specific adult tissues (bone marrow, fat, skin); more limited differentiation potential (multipotent); no embryo destruction; less controversial |
| Haematopoietic Stem Cells (HSCs) | Blood-forming stem cells from bone marrow or cord blood; the ONLY stem cell type with a proven, approved clinical application in India; used in bone marrow transplants for blood cancers (leukaemia, lymphoma, aplastic anaemia) |
| iPSC (Induced Pluripotent Stem Cells) | Adult cells (e.g., skin cells) reprogrammed to become embryonic-like pluripotent cells; discovered by Shinya Yamanaka (Nobel Prize 2012); avoids embryo controversy; key research tool |
| Cord blood stem cells | Stem cells from the umbilical cord blood after birth; rich in HSCs; collected and stored in cord blood banks; used in haematological treatments |
[Additional] Stem Cell Research — ICMR Guidelines 2025, Therapeutic Applications, and Ethical Governance (GS2 — Health / GS3 — Science and Technology):
India's stem cell regulatory framework:
| Document | Issuing body | Year | Key provisions |
|---|---|---|---|
| National Guidelines for Stem Cell Research 2025 | ICMR (Indian Council of Medical Research) + DBT | 2025 (updated from 2017 version) | Research categorised as "permissible," "restrictive," or "prohibited"; ethical oversight requirements |
| National Guidelines 2017 | ICMR + DBT | 2017 | Earlier version; updated to reflect advances in iPSC, gene editing (CRISPR) + organoids |
| IC-SCRT (Institutional Committee for Stem Cell Research) | Each research institution | Required | Institutional oversight body for stem cell research |
| NAC-SCRT | National Apex Committee | Dissolved 2024 | National oversight committee dissolved March 2024 citing implementation difficulties |
Classification of stem cell research (ICMR 2025):
| Category | Meaning | Examples |
|---|---|---|
| Permissible | Allowed without special approval beyond IC-SCRT | Adult stem cell research, cord blood banking, HSC transplants, iPSC research, organoid models |
| Restrictive | Requires additional oversight (IC-SCRT + external review) | Human embryonic stem cell research (limited conditions); some gene editing research |
| Prohibited | Banned in India | Human reproductive cloning; creating human-animal chimeras for reproduction; germline gene editing for heritable changes |
The only APPROVED clinical application of stem cells in India (2025):
| Application | Detail |
|---|---|
| Haematopoietic Stem Cell Transplantation (HSCT) | Also called bone marrow transplant; uses HSCs from bone marrow, peripheral blood, or cord blood; ONLY approved clinical indication under ICMR guidelines |
| Diseases treated | Leukaemia (blood cancer), lymphoma, multiple myeloma, aplastic anaemia, thalassaemia, sickle cell disease |
| Source of HSCs | Autologous (patient's own cells — before chemotherapy) OR allogenic (matched donor) |
| India HSCT growth | ~3,000–4,000 HSCT procedures/year in India (2024) — growing with more centres in Tier-2 cities |
The problem of unproven stem cell therapies in India:
| Issue | Detail |
|---|---|
| Unregulated clinics | Many private clinics offer "stem cell therapy" for autism, cerebral palsy, spinal cord injury, Parkinson's — NONE of these are approved indications in India |
| ICMR position | Only HSCT is approved; all other therapeutic uses = experimental = must be under clinical trial protocol |
| Risk | Unproven stem cell injections have caused infections, tumour growth, and deaths in some reported cases globally |
| NAC-SCRT dissolution | The dissolution of the National Apex Committee in March 2024 has raised concerns about reduced national-level oversight |
| CDSCO role | Central Drugs Standard Control Organisation (under MoHFW) attempts to regulate stem cell products as "drugs" but enforcement is uneven |
iPSC and the future — Yamanaka's Nobel Prize:
| Discovery | Detail |
|---|---|
| Shinya Yamanaka (Japan) | Discovered that adult cells can be reprogrammed to pluripotency by introducing 4 transcription factors (Oct4, Sox2, Klf4, c-Myc) — Nobel Prize in Physiology or Medicine 2012 (jointly with John Gurdon) |
| Why iPSCs matter | No embryo destruction; patient-specific cells (no immune rejection); unlimited supply from adult cells |
| Applications | Drug testing models (organoids from patient iPSCs); disease modelling; future personalized cell therapy |
| India's iPSC research | NCBS (Bengaluru), NIMHANS, CCMB (Hyderabad), InStem (Bengaluru) all have active iPSC research programmes |
UPSC synthesis: Key exam facts: ICMR + DBT issued National Guidelines for Stem Cell Research 2025 (updated from 2017); research categorised as permissible / restrictive / prohibited; ONLY approved clinical use in India = Haematopoietic Stem Cell Transplantation (HSCT) = bone marrow transplant; reproductive cloning + human-animal chimeras = prohibited; Yamanaka = iPSC = Nobel 2012; NAC-SCRT (national oversight committee) dissolved March 2024 — raised governance concerns; many unproven clinics claiming stem cell cures for autism/CP/Parkinson's = NOT approved by ICMR. Prelims trap: The ONLY approved clinical use of stem cells in India is HSCT (bone marrow transplant for blood disorders) — stem cell therapy for autism, cerebral palsy, spinal cord injury are NOT approved in India; iPSC was discovered by Shinya Yamanaka (Japan) and won the Nobel Prize in 2012 (NOT CRISPR — that's Jennifer Doudna/Emmanuelle Charpentier, Nobel 2020); ICMR issues the stem cell guidelines (jointly with DBT) — NOT the Supreme Court or Parliament (these are administrative guidelines, not legislation).
Exam Strategy
Prelims traps:
- Blood is a connective tissue — not a fluid tissue separate from connective tissue.
- Xylem transport is unidirectional (up); phloem is bidirectional.
- Cardiac muscle is involuntary AND striated — the only such combination.
- Sclerenchyma cells are dead at maturity unlike collenchyma which remains living.
- Companion cells support sieve tube elements because sieve tubes lack a nucleus.
Mains frameworks (tissue → policy):
- Organ donation: tissue science → THOTA Act → NOTTO → international comparisons
- Anaemia policy: blood tissue science → iron deficiency → POSHAN Abhiyaan → National Nutrition Mission
- AMR and tissue infection: how pathogens invade epithelial barriers → antibiotic policy
Practice Questions
Q1 (Prelims 2020): With reference to blood, which of the following statements is/are correct? (Tests: blood as connective tissue, components of blood)
Q2 (Prelims 2018): Consider the following statements about stem cells... (Tests: understanding of undifferentiated cells and their potential)
Q3 (Mains GS2 2019): "India's organ donation rate is abysmally low." Examine the reasons and suggest measures to improve it. Tissue science link: requires understanding of what organs and tissues can be transplanted, legal framework.
Q4 (Prelims 2015): In the context of the human body, which one of the following is correctly matched? (Tests: classification of tissues — blood/bone/cartilage as connective tissue)
BharatNotes